{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T09:21:27Z","timestamp":1774689687171,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000672","name":"Pathological Society of Great Britain and Ireland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000672","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001308","name":"Jean Shanks Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001308","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wellcome Trust, Medical Research Council"},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001275","name":"Oak Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001275","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009729","name":"Ludwig Institute for Cancer Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009729","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIHR Academic Clinical Fellowship programme"},{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.placenta.2017.03.010","type":"journal-article","created":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T18:22:34Z","timestamp":1489688554000},"page":"8-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"special_numbering":"C","title":["Hypoxia and HIF pathway in cancer and the placenta"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7750-3242","authenticated-orcid":false,"given":"Philip S.","family":"Macklin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"McAuliffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5170-1662","authenticated-orcid":false,"given":"Christopher W.","family":"Pugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0120-1982","authenticated-orcid":false,"given":"Atsushi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.placenta.2017.03.010_bib1","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJMra0910283","article-title":"Hypoxia and inflammation","volume":"364","author":"Eltzschig","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"6","key":"10.1016\/j.placenta.2017.03.010_bib2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1056\/NEJMra1011165","article-title":"Oxygen sensing, homeostasis, and disease","volume":"365","author":"Semenza","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"6","key":"10.1016\/j.placenta.2017.03.010_bib3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1095\/biolreprod.112.102723","article-title":"The role of hypoxia and hypoxia-inducible factor-1alpha in preeclampsia pathogenesis","volume":"87","author":"Tal","year":"2012","journal-title":"Biol. Reprod."},{"issue":"1","key":"10.1016\/j.placenta.2017.03.010_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cell.2016.08.036","article-title":"Into thin air: how we sense and respond to hypoxia","volume":"167","author":"Thompson","year":"2016","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.placenta.2017.03.010_bib5","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","article-title":"Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension","volume":"92","author":"Wang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.placenta.2017.03.010_bib6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1101\/gad.11.1.72","article-title":"Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells","volume":"11","author":"Tian","year":"1997","journal-title":"Genes Dev."},{"issue":"9","key":"10.1016\/j.placenta.2017.03.010_bib7","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1073\/pnas.94.9.4273","article-title":"A\u00a0novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development","volume":"94","author":"Ema","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"36","key":"10.1016\/j.placenta.2017.03.010_bib8","doi-asserted-by":"crossref","first-page":"32405","DOI":"10.1074\/jbc.C200328200","article-title":"Inhibitory PAS domain protein (IPAS) is a hypoxia-inducible splicing variant of the hypoxia-inducible factor-3alpha locus","volume":"277","author":"Makino","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"issue":"6733","key":"10.1016\/j.placenta.2017.03.010_bib9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"issue":"5516","key":"10.1016\/j.placenta.2017.03.010_bib10","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing","volume":"292","author":"Ivan","year":"2001","journal-title":"Science"},{"issue":"5516","key":"10.1016\/j.placenta.2017.03.010_bib11","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.placenta.2017.03.010_bib12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0092-8674(01)00507-4","article-title":"C.\u00a0elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation","volume":"107","author":"Epstein","year":"2001","journal-title":"Cell"},{"issue":"5556","key":"10.1016\/j.placenta.2017.03.010_bib13","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1126\/science.1068592","article-title":"Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch","volume":"295","author":"Lando","year":"2002","journal-title":"Science"},{"issue":"29","key":"10.1016\/j.placenta.2017.03.010_bib14","doi-asserted-by":"crossref","first-page":"26351","DOI":"10.1074\/jbc.C200273200","article-title":"Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family","volume":"277","author":"Hewitson","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"issue":"1","key":"10.1016\/j.placenta.2017.03.010_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.tibs.2010.07.002","article-title":"Physiological and biochemical aspects of hydroxylations and demethylations catalyzed by human 2-oxoglutarate oxygenases","volume":"36","author":"Loenarz","year":"2011","journal-title":"Trends Biochem. Sci."},{"issue":"2","key":"10.1016\/j.placenta.2017.03.010_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1535-6108(03)00187-9","article-title":"TSC2 regulates VEGF through mTOR-dependent and -independent pathways","volume":"4","author":"Brugarolas","year":"2003","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.placenta.2017.03.010_bib17","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1074\/jbc.M608337200","article-title":"Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates","volume":"282","author":"Hewitson","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"issue":"7","key":"10.1016\/j.placenta.2017.03.010_bib18","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1074\/jbc.M610415200","article-title":"Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF","volume":"282","author":"Koivunen","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.placenta.2017.03.010_bib19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/978-1-4899-7678-9_18","article-title":"Modulation of the hypoxic response","volume":"903","author":"Pugh","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"issue":"5","key":"10.1016\/j.placenta.2017.03.010_bib20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrm1366","article-title":"Oxygen sensing by HIF hydroxylases","volume":"5","author":"Schofield","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.placenta.2017.03.010_bib21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4161\/cc.5.5.2497","article-title":"Hypoxia, HIF and the placenta","volume":"5","author":"Fryer","year":"2006","journal-title":"Cell Cycle"},{"issue":"2","key":"10.1016\/j.placenta.2017.03.010_bib22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/dbio.1997.8758","article-title":"ARNT-deficient mice and placental differentiation","volume":"191","author":"Kozak","year":"1997","journal-title":"Dev. Biol."},{"issue":"23","key":"10.1016\/j.placenta.2017.03.010_bib23","doi-asserted-by":"crossref","first-page":"10479","DOI":"10.1128\/MCB.25.23.10479-10491.2005","article-title":"Hypoxia-inducible factors 1alpha and 2alpha regulate trophoblast differentiation","volume":"25","author":"Cowden Dahl","year":"2005","journal-title":"Mol. Cell Biol."},{"issue":"17","key":"10.1016\/j.placenta.2017.03.010_bib24","doi-asserted-by":"crossref","first-page":"9102","DOI":"10.1073\/pnas.94.17.9102","article-title":"Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice","volume":"94","author":"Gnarra","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"22","key":"10.1016\/j.placenta.2017.03.010_bib25","doi-asserted-by":"crossref","first-page":"8336","DOI":"10.1128\/MCB.00425-06","article-title":"Placental but not heart defects are associated with elevated hypoxia-inducible factor alpha levels in mice lacking prolyl hydroxylase domain protein 2","volume":"26","author":"Takeda","year":"2006","journal-title":"Mol. Cell Biol."},{"issue":"7381","key":"10.1016\/j.placenta.2017.03.010_bib26","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature10762","article-title":"Clonal evolution in cancer","volume":"481","author":"Greaves","year":"2012","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.placenta.2017.03.010_bib27","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1128\/MCB.25.13.5675-5686.2005","article-title":"Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma","volume":"25","author":"Raval","year":"2005","journal-title":"Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.placenta.2017.03.010_bib28","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ccr.2007.02.006","article-title":"HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity","volume":"11","author":"Gordan","year":"2007","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.placenta.2017.03.010_bib29","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ccr.2011.09.006","article-title":"Renal cyst formation in Fh1-deficient mice is independent of the Hif\/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling","volume":"20","author":"Adam","year":"2011","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.placenta.2017.03.010_bib30","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1095\/biolreprod59.3.643","article-title":"Vascular endothelial growth factor stimulates proliferation but not migration or invasiveness in human extravillous trophoblast","volume":"59","author":"Athanassiades","year":"1998","journal-title":"Biol. Reprod."},{"issue":"3","key":"10.1016\/j.placenta.2017.03.010_bib31","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1677\/erc.1.01221","article-title":"Vascular endothelial growth factor induces proliferation of breast cancer cells and inhibits the anti-proliferative activity of anti-hormones","volume":"13","author":"Liang","year":"2006","journal-title":"Endocr. Relat. Cancer"},{"issue":"3","key":"10.1016\/j.placenta.2017.03.010_bib32","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3892\/ijo.2015.3082","article-title":"Vascular endothelial growth factor directly stimulates tumour cell proliferation in non-small cell lung cancer","volume":"47","author":"Devery","year":"2015","journal-title":"Int. J. Oncol."},{"issue":"9","key":"10.1016\/j.placenta.2017.03.010_bib33","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","article-title":"Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1","volume":"16","author":"Forsythe","year":"1996","journal-title":"Mol. Cell Biol."},{"issue":"38","key":"10.1016\/j.placenta.2017.03.010_bib34","doi-asserted-by":"crossref","first-page":"23659","DOI":"10.1074\/jbc.272.38.23659","article-title":"Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1\/KDR, is up-regulated by hypoxia","volume":"272","author":"Gerber","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"issue":"7","key":"10.1016\/j.placenta.2017.03.010_bib35","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0143-4004(98)91039-6","article-title":"Role of placenta growth factor (PIGF) in human extravillous trophoblast proliferation, migration and invasiveness","volume":"19","author":"Athanassiades","year":"1998","journal-title":"Placenta"},{"issue":"1","key":"10.1016\/j.placenta.2017.03.010_bib36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3858\/emm.2012.44.1.023","article-title":"Role of placenta growth factor in cancer and inflammation","volume":"44","author":"Kim","year":"2012","journal-title":"Exp. Mol. Med."},{"issue":"6711","key":"10.1016\/j.placenta.2017.03.010_bib37","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/25141","article-title":"Control of apoptosis and mitotic spindle checkpoint by survivin","volume":"396","author":"Li","year":"1998","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.placenta.2017.03.010_bib38","first-page":"965","article-title":"Localization of telomerase hTERT protein and survivin in placenta: relation to placental development and hydatidiform mole","volume":"97","author":"Lehner","year":"2001","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.placenta.2017.03.010_bib39","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1447-0756.2012.01995.x","article-title":"Hypoxia inducible factor-1alpha-mediated activation of survivin in cervical cancer cells","volume":"39","author":"Bai","year":"2013","journal-title":"J.\u00a0Obstet. Gynaecol. Res."},{"issue":"3","key":"10.1016\/j.placenta.2017.03.010_bib40","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1600-0897.2010.00837.x","article-title":"Placental apoptosis in health and disease","volume":"64","author":"Sharp","year":"2010","journal-title":"Am. J. Reprod. Immunol."},{"issue":"3\u20134","key":"10.1016\/j.placenta.2017.03.010_bib41","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10555-007-9080-0","article-title":"The role of the hypoxia-inducible BH3-only proteins BNIP3 and BNIP3L in cancer","volume":"26","author":"Mellor","year":"2007","journal-title":"Cancer Metastasis Rev."},{"issue":"6","key":"10.1016\/j.placenta.2017.03.010_bib42","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.2353\/ajpath.2008.080380","article-title":"Expression profiling of Galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry","volume":"173","author":"Mourad-Zeidan","year":"2008","journal-title":"Am. J. Pathol."},{"issue":"5\u20136","key":"10.1016\/j.placenta.2017.03.010_bib43","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0143-4004(97)80044-6","article-title":"Changes in the distribution pattern of galectin-1 and galectin-3 in human placenta correlates with the differentiation pathways of trophoblasts","volume":"18","author":"Maquoi","year":"1997","journal-title":"Placenta"},{"issue":"4","key":"10.1016\/j.placenta.2017.03.010_bib44","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/cam4.105","article-title":"Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment?","volume":"2","author":"Donnem","year":"2013","journal-title":"Cancer Med."},{"issue":"4","key":"10.1016\/j.placenta.2017.03.010_bib45","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2183\/pjab.87.167","article-title":"Involvement of Flt-1 (VEGF receptor-1) in cancer and preeclampsia","volume":"87","author":"Shibuya","year":"2011","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"issue":"4","key":"10.1016\/j.placenta.2017.03.010_bib46","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1091\/mbc.e04-12-1082","article-title":"Hypoxia-inducible factor regulates alphavbeta3 integrin cell surface expression","volume":"16","author":"Cowden Dahl","year":"2005","journal-title":"Mol. Biol. Cell"},{"issue":"9","key":"10.1016\/j.placenta.2017.03.010_bib47","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1172\/JCI119387","article-title":"Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?","volume":"99","author":"Zhou","year":"1997","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.placenta.2017.03.010_bib48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1477-7827-2-15","article-title":"Trophoblast 'pseudo-tumorigenesis': significance and contributory factors","volume":"2","author":"Soundararajan","year":"2004","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"5","key":"10.1016\/j.placenta.2017.03.010_bib49","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"24","key":"10.1016\/j.placenta.2017.03.010_bib50","doi-asserted-by":"crossref","first-page":"7185","DOI":"10.1158\/0008-5472.CAN-14-2598","article-title":"Mechanisms of hypoxia-mediated immune escape in cancer","volume":"74","author":"Barsoum","year":"2014","journal-title":"Cancer Res."},{"issue":"Suppl","key":"10.1016\/j.placenta.2017.03.010_bib51","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/j.semcancer.2015.03.004","article-title":"Immune evasion in cancer: mechanistic basis and therapeutic strategies","volume":"35","author":"Vinay","year":"2015","journal-title":"Semin. Cancer Biol."},{"issue":"11","key":"10.1016\/j.placenta.2017.03.010_bib52","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0025-6196(11)60669-1","article-title":"Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents","volume":"84","author":"Holtan","year":"2009","journal-title":"Mayo Clin. Proc."},{"issue":"6","key":"10.1016\/j.placenta.2017.03.010_bib53","first-page":"2005","article-title":"Tumour MHC class I downregulation and immunotherapy (Review)","volume":"10","author":"Bubenik","year":"2003","journal-title":"Oncol. Rep."},{"issue":"39","key":"10.1016\/j.placenta.2017.03.010_bib54","doi-asserted-by":"crossref","first-page":"63690","DOI":"10.18632\/oncotarget.11628","article-title":"Hypoxia inducible factor-1 mediates the expression of the immune checkpoint HLA-G in glioma cells through hypoxia response element located in exon 2","volume":"7","author":"Yaghi","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.placenta.2017.03.010_bib55","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1165\/rcmb.2015-0266OC","article-title":"Inhibition of prolyl hydroxylase attenuates Fas ligand-induced apoptosis and lung injury in mice","volume":"55","author":"Nagamine","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"2","key":"10.1016\/j.placenta.2017.03.010_bib56","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1084\/jem.20050019","article-title":"A\u00a0critical role for the programmed death ligand 1 in fetomaternal tolerance","volume":"202","author":"Guleria","year":"2005","journal-title":"J.\u00a0Exp. Med."},{"issue":"3","key":"10.1016\/j.placenta.2017.03.010_bib57","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1158\/0008-5472.CAN-13-0992","article-title":"A\u00a0mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells","volume":"74","author":"Barsoum","year":"2014","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.placenta.2017.03.010_bib58","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1095\/biolreprod.105.046581","article-title":"Trophoblast CD274 (B7-H1) is differentially expressed across gestation: influence of oxygen concentration","volume":"74","author":"Holets","year":"2006","journal-title":"Biol. Reprod."},{"issue":"1","key":"10.1016\/j.placenta.2017.03.010_bib59","doi-asserted-by":"crossref","first-page":"C477","DOI":"10.1152\/ajpcell.00075.2007","article-title":"Hypoxic upregulation of glucose transporters in BeWo choriocarcinoma cells is mediated by hypoxia-inducible factor-1","volume":"293","author":"Baumann","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"2","key":"10.1016\/j.placenta.2017.03.010_bib60","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3892\/ijo.2015.3056","article-title":"Overexpression of hypoxia-inducible factor 1alpha induces migration and invasion through Notch signaling","volume":"47","author":"Tian","year":"2015","journal-title":"Int. J. Oncol."}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400417301959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400417301959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:56:49Z","timestamp":1758909409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400417301959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":60,"alternative-id":["S0143400417301959"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2017.03.010","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypoxia and HIF pathway in cancer and the placenta","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2017.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}